ImmuCell Corporation: accounts_receivable
| Value | {"amount": 1701830, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-09-30) |
| Status | current |
| Entity | ImmuCell Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:07:43.661981+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3f24c1c0-bfd8-4bef-b8ab-fc90fa2c875f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-22-074215Retrieved: 2026-08-19T08:07:43.661981+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000811641/accounts-receivable/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3f24c1c0-bfd8-4bef-b8ab-fc90fa2c875f
History
- no predecessors — first report